Oftal Genetic Test
The test is performed by NGS sequencing of the whole genome and allows a complete screening of the DNA (intragenic and intergenic regions).
Genetics plays a key role in the regulation of diseases: the OPHTHALMOLOGICAL PANEL analyzes more than 400 conditions with specific information on the common and rare variants associated with diseases related to the visual apparatus and its annexes.
The analysis of the genome will allow professionals to develop an individual food plan and medical therapy, aimed at the prevention or treatment of diseases related to the visual apparatus.
DISEASES OF THE VISUAL APPARATUS INVESTIGATED
A DNA sequencing test to assess susceptibility to diseases related to the visual apparatus.
-
Macular degenerations
-
Conical-red dystrophy
-
Ectopia Lentis
-
Bardet-Biedl syndrome
-
Severe myopia
-
Cataract
-
Achromatopsia
-
Retinopathies
-
… And other less common conditions.
INFORMATION MATERIAL
Intestinal Microbiome
Metagenomic analysis for the characterization of the intestinal microbiota
THE TEST
The screening involves the investigation of a series of bacterial and fungal phylums capable of influencing the composition and balance of the intestinal microbiota, correlating them with the main physiological functions of the host and identifying and characterizing any situations of intestinal dysbiosis.
WHY DO IT
An increasing number of researches shows how a condition of dysbiosis at the level of the intestinal microbiota predisposes the subject to the development of various problems such as lack of essential nutrients such as folic acid and vitamin D, metabolic syndrome, gastrointestinal problems, headaches, insomnia, muscle and joint pain, up to chronic degenerative conditions or autoimmune disorders, such as diabetes and rheumatoid arthritis, or chronic inflammatory bowel diseases (IBD), such as Crohn's disease (CD) and ulcerative colitis (CU).
The test is very useful for preventive purposes but also in subjects in which certain problems have already arisen, as well as in patients in particular stages of life such as pregnancy, breastfeeding, menopause, childhood and aging, to address a specific food plan and / or a therapeutic approach.
TYPE OF ANALYSIS
The analysis performed starts from fecal sampling and is based on the molecular evaluation of the intestinal microbiome through gene sequencing with Next Generation Sequencing (NGS) technology, which allows to obtain the composition of an individual's microbiome and identify any alterations at the level of its components.
The metagenomic analysis allows the simultaneous analysis of a community of microorganisms present in a sample, to investigate the specific functions of this community and the interactions with the organism that hosts it.
INFORMATION MATERIAL
Below is all the information and advertising material available in relation to the panel.
